- Tytuł:
- Response to “Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis’”
- Autorzy:
- Źródło:
- Dermatology and Therapy: Research, treatment and aesthetic interventions in dermatology. 14(3):823-827
Czasopismo naukowe